Skip navigation

Boston Scientific shares jump on strong 2Q results

Shares of Boston Scientific Corp. jumped Thursday after the medical device maker reported better-than-expected earnings from sales of its stents and other cardiovascular devices. Full story

Boston Scientific second-quarter profit beats, shares rise

(Reuters) - Boston Scientific Corp <BSX.N> on Thursday reported a second-quarter profit that beat expectations and forecast growth in the third period on improved sales of its surgical devices and cardiology products. Full story

Boston Scientific downgraded on recent share rise

A Citi Investment Research analyst downgraded shares of Boston Scientific Corp. Monday as the medical device maker's stock traded around three-year highs. Full story

Boston Scientific spends $275M on CR Bard business

Boston Scientific Corp. plans to spend $275 million to buy the electrophysiology business of fellow medical device maker C.R. Bard Inc. and strengthen its stake in a $2.5 billion global market. Full story

Boston Scientific sees market share growth in heart devices

(Reuters) - Medical device maker Boston Scientific Corp said it expects to grow faster than the overall market for implantable heart devices, which has been struggling in recent years amid weak worldwide demand. Full story

Boston Scientific reports weaker results, sets job cuts

(Reuters) - Boston Scientific Corp <BSX.N> reported weaker quarterly earnings on Tuesday as sales slipped and expenses rose, and the medical device maker announced more job cuts. Full story

Sponsored Links
advertisement | ad info